Sanger Life

Innovation

  • 1 December 2024

    Based originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.

Human Cell Atlas

  • 1 May 2024

    Lab-grown organoids that mimic human skin are enabling new research into development and disease. Dr April Rose Foster sat down with us to talk about working with the cells and her hopes for the future of research into skin disease.

Tree of Life

  • 18 July 2025

    Filled with colour-coding chromosomes and genome re-arrangements, learn more about some of our resident moths and butterflies that have been genome sequenced at the Wellcome Sanger Institute. With a bit of luck, you could identify these colourful creatures yourself next time you are out and about.